The Impact of Recombinant DNA Technology on the Study of Enterovirus Heart Disease

  • Reinhard Kandolf
Part of the Infectious Agents and Pathogenesis book series (IAPA)


Of the numerous viruses associated with acute infectious myocarditis, coxsackieviruses (CV) of group B (CVB) types 1–5 are generally accepted as the most common agents.1–13 Various Coxsackie A viruses (CVA) and echoviruses are also relatively common causes of human viral heart disease.


Dilate Cardiomyopathy Vero Cell Endomyocardial Biopsy Nucleic Acid Hybridization Replicase Gene 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Abelmann, W. H., 1973. Clinical aspects of viral cardiomyopathy, in: Myocardial Diseases (N. O. Fowler, ed.), pp. 253–279, Grune & Stratton, New York.Google Scholar
  2. 2.
    Lerner, A. M., and Wilson, F. M., 1973, Virus myocardiopathy, Prog. Med. Virol. 15:63–91.PubMedGoogle Scholar
  3. 3.
    Grist, N. R., 1977, Coxsackie virus infections of the heart, Rec. Adv. Clin. Virol. 1:141 – 150.Google Scholar
  4. 4.
    Landsdown, A. B. G., 1978, Viral infections and diseases of the heart, Prog. Med. Virol. 24:70–113.Google Scholar
  5. 5.
    Levine, H. D., 1979, Virus myocarditis: A critique of the literature from clinical, electrocardiographic, and pathologic standpoints, Am. J. Med. Sci. 277:132–143.PubMedCrossRefGoogle Scholar
  6. 6.
    Woodruff, J. F., 1980, Viral myocarditis, Am. J. Pathol. 101:427–479.Google Scholar
  7. 7.
    Wynne, J., and Braunwald, E., 1980, The cardiomyopathies and myocarditides, in: Heart Disease. A Textbook of Cardiovascular Medicine (E. Braunwald, ed.), pp. 1437–1498, W. B. Saunders, Philadelphia.Google Scholar
  8. 8.
    Johnson, R. A., and Palacios, I., 1982, Dilated cardiomyopathies of the adult, N. Engl. J. Med. 307:1119–1126.PubMedCrossRefGoogle Scholar
  9. 9.
    Melnick, J. L., 1984, Enteroviruses, in: Viral Infections of Humans, 2nd ed., (A. S. Evans, ed.), pp. 187–251, Plenum, New York.CrossRefGoogle Scholar
  10. 10.
    Boite, H. D., ed., 1984, Viral Heart Disease, Springer-Verlag, New York.Google Scholar
  11. 11.
    Reyes, M. P., and Lerner, A. M., 1985, Coxsackievirus myocarditis—with special reference to acute and chronic effects, Prog. Cardiovasc. Dis. 27:373–394.PubMedCrossRefGoogle Scholar
  12. 12.
    Melnick, J. L., 1983, Portraits of viruses: The picornaviruses, Intervirology 20:61–100.PubMedCrossRefGoogle Scholar
  13. 13.
    Putnak, J. R., and Phillips, B. A., 1981, Picornaviral structure and assembly, Microbiol. Rev. 45:287–315.PubMedGoogle Scholar
  14. 14.
    Cambridge, G., MacArthur, C. G. C., Waterson, A. P., Goodwin, J. F., and Oakley, C. M., 1979, Antibodies to Coxsackie B viruses in congestive cardiomyopathy, Br. Heart J. 41:692–696.PubMedCrossRefGoogle Scholar
  15. 15.
    Waterson, A. P., 1980, Coxsackie viruses in acute and chronic cardiac disease, in: Myocardial Biopsy (H. D. Boite, ed.), pp. 116–118, Springer-Verlag, New York.CrossRefGoogle Scholar
  16. 16.
    Kuhn, H., Breithardt, G., Knieriem, H. J., Loogen, F., Both, A., Schmidt, W. A. K., Stroobandt, R., and Gleichmann, U., 1975, Die Bedeutung der endomyokardialen Katheterbiopsie für die Diagnostik und die Beurteilung der Prognose der kongestiven Kardiomyopathie, Dtsch. Med. Wochenschr. 100:717–723.PubMedCrossRefGoogle Scholar
  17. 17.
    Sutton, G. C., Harding, H. B., Trueheart, R. P., and Clark, H. P., 1967, Coxsackie B4 myocarditis in an adult: Successful isolation of virus from ventricular myocardium, Aerospace Med. 38:66–69.Google Scholar
  18. 18.
    Kandolf, R., and Hofschneider, P. H., 1984, Effect of interferon on the replication of Coxsackie B3 virus in cultured human fetal heart cells, in: Viral Heart Disease (H. D. Boite, ed.), pp. 57–63, Springer-Verlag, New York.CrossRefGoogle Scholar
  19. 19.
    Kandolf, R., Canu, A., and Hofschneider, P. H., 1985, Coxsackie B3 virus can replicate in cultured human foetal heart cells and is inhibited by interferon, J.Mol. Cell. Cardiol. 17:167–181.CrossRefGoogle Scholar
  20. 20.
    Stewart II, W. E., 1981, The Interferon System, 2nd ed., Springer-Verlag, Wien.Google Scholar
  21. 21.
    Kandolf, R., and Hof Schneider, P. H., 1985, Molecular cloning of the genome of a cardiotropic Coxsackie B3 virus: Full-length reverse-transcribed recombinant cDNA generates infectious virus in mammalian cells, Proc. Natl. Acad. Sci. USA 82:4818–4822.PubMedCrossRefGoogle Scholar
  22. 22.
    Dec, G. W., Palacios, I. F., Fallon, J. T., Aretz, H. T., Mills, J., Lee, D. C.-S., and Johnson, R. A., 1985, Active myocarditis in the spectrum of acute dilated cardiomypa-thies, N. Engl. J. Med. 312:885–890.PubMedCrossRefGoogle Scholar
  23. 23.
    Mason, J. W., 1978, Techniques for right and left ventricular endomyocardial biopsy, Am. J. Cardiol. 41:887–892.PubMedCrossRefGoogle Scholar
  24. 24.
    Parrillo, J. E., Aretz, H. T., Palacios, I., Fallon, J. T., and Block, P. C., 1984, The results of transvenous endomyocardial biopsy can frequently be used to diagnose myocardial diseases in patients with idiopathic heart failure, Circulation 69:93–101.PubMedCrossRefGoogle Scholar
  25. 25.
    Godman, G. C., 1973, Picornaviruses, in: Ultrastructure of Animal Viruses and Bacteriophages (A. J. Dalton and F. Haguenau, eds.), pp. 133–153, Academic, New York.Google Scholar
  26. 26.
    Melnick, J. L., Wenner, H. A., and Phillips, C. A., 1979, Enteroviruses, in: Diagnostic Procedures for Viral, Rickettsial and Chlamydial Infections, 5th ed. (E. H. Lennette and N. J. Schmidt, eds.), pp. 471–534, American Public Health Assoc, Washington, D.C.Google Scholar
  27. 27.
    Engleberg, N. C., and Eisenstein, B. I., 1984, The impact of new cloning techniques on the diagnosis and treatment of infectious diseases, N. Engl. J. Med. 311:892–901.PubMedCrossRefGoogle Scholar
  28. 28.
    Bornkamm, G. W., Desgranges, C., and Gissmann, L., 1983, Nucleic acid hybridization for the detection of viral genomes, Curr. Top. Microbiol. Immunol. 104:287–298.PubMedCrossRefGoogle Scholar
  29. 29.
    Okayama, H., and Berg, P., 1982, High-efficiency cloning of full-length cDNA, Mol. Cell. Biol. 2:161–170.PubMedGoogle Scholar
  30. 30.
    Gubler, U., and Hoffman, B. J., 1983, A simple and very efficient method for generating cDNA libraries, Gene 25:263–269.PubMedCrossRefGoogle Scholar
  31. 31.
    Hanahan, D., 1983, Studies on transformation of Escherichia coli with plasmids, J.Mol. Biol. 166:557–580.CrossRefGoogle Scholar
  32. 32.
    Maniatis, T., Fritsch, E. F., and Sambrook, J., 1982, Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York.Google Scholar
  33. 33.
    Racaniello, V. R., and Baltimore, D., 1981, Cloned poliovirus complementary DNA is infectious in mammalian cells, Science 214:916–919.PubMedCrossRefGoogle Scholar
  34. 34.
    Semler, B. L., Dorner, A. J., and Wimmer, E., 1984, Production of infectious poliovirus from cloned cDNA is dramatically increased by SV40 transcription and replication signals, Nucleic Acids Res. 12:5123–5141.PubMedCrossRefGoogle Scholar
  35. 35.
    Omata, T., Kohara, M., Sakai, Y., Kameda, A., Imura, N., and Nomoto, A., 1984, Cloned infectious complementary DNA of the poliovirus Sabin 1 genome: Biochemical and biological properties of the recovered virus, Gene 32:1–10.PubMedCrossRefGoogle Scholar
  36. 36.
    Thomas, P. S., 1980, Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose, Proc. Natl. Acad. Sci. USA 77:5201–5205.PubMedCrossRefGoogle Scholar
  37. 37.
    Hyypiä, T., Stålhandske, P. Vainionpää, R., and Pettersson, U., 1984, Detection of enteroviruses by spot hybridization, J. Clin. Microbiol. 19:436–438.Google Scholar
  38. 38.
    Tracy, S., 1984, A comparison of genomic homologies among the coxsackievirus B group: Use of fragments of the cloned coxsackievirus B3 genome as probes,J.Gen. Virol. 65:2167–2172.PubMedCrossRefGoogle Scholar
  39. 39.
    Bowles, N. E., Richardson, P. J., Olsen, E. G. J., and Archard, L. C., 1986, Detection of coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy, Lancet 1:1120–1123.PubMedCrossRefGoogle Scholar
  40. 40.
    Rancaniello, V. R., and Baltimore, D., 1981, Molecular cloning of poliovirus cDNA and determination of the complete nucleotide sequence of the viral genome, Proc. Natl. Acad. Sci. USA 78:4887–4891.CrossRefGoogle Scholar
  41. 41.
    Maxam, A. M., and Gilbert, W., 1977, A new method for sequencing DNA, Proc. Natl. Acad. Sci. USA 74:560–564.PubMedCrossRefGoogle Scholar
  42. 42.
    Stålhandske, P. O. K., Lindberg, M., and Pettersson, U., 1984, Replicase gene of coxsackievirus B3,J.Virol. 51:742–746.PubMedGoogle Scholar
  43. 43.
    Crowell, R. L., and Philipson, L., 1971, Specific alterations of coxsackievirus B3 eluted from Hela cells,J.Virol. 8:509–515.PubMedGoogle Scholar
  44. 44.
    Rueckert, R. R., and Wimmer, E., 1984, Systematic nomenclature of picornavirus proteins,J.Virol. 50:957–959.PubMedGoogle Scholar
  45. 45.
    Gall, J. G., and Pardue, M. L., 1969, Formation and detection of RNA-DNA hybrid molecules in cytological preparations, Proc. Natl. Acad. Sci. USA 63:378–391.PubMedCrossRefGoogle Scholar
  46. 46.
    Wolf, H., zur Hausen, H., and Becker, V., 1973, EB viral genomes in epithelial nasopharyngeal carcinoma cells, Nature New Biol. 244:245–247.PubMedGoogle Scholar
  47. 47.
    Falser, N., Bandtlow, I., Haus, M., and Wolf, H. 1986, Detection of Pseudorabies virus DNA in the inner ear of intranasally infected BALB/c mice with nucleic acid hybridization in situ J. Virol. 57:335–339.PubMedGoogle Scholar
  48. 48.
    Haase, A., Brahic, M., Stowring, L., and Blum, H., 1984. Detection of viral nucleic acids by in situ hybridization, in: Methods in Virology, Vol. 7 (K. Maramorosh and H. Koprowski, eds.) pp. 189–226, Academic, New York.Google Scholar
  49. 49.
    Johnson, M. T., and Johnson, B. A., 1984, Efficient synthesis of high specific activity (35S)-labeled human β-globin pre-mRNA, Biotechniques 2:156–162.Google Scholar
  50. 50.
    Remaut, E., Stanssens, P., and Fiers, W., 1981, Plasmid vectors for high-efficiency expression controlled by the pL promoter of coliphage lambda, Gene 15:81–93.PubMedCrossRefGoogle Scholar
  51. 51.
    Klump, W., Marquardt, O., and Hofschneider, P. H., 1984, Biologically active protease of foot and mouth disease virus is expressed from cloned viral cDNA in Escherichia coli, Proc. Natl. Acad. Sci. USA 81:3351–3355.CrossRefGoogle Scholar
  52. 52.
    Klump, W., Soppa, J., Marquardt, O., and Hofschneider, P. H., 1984, Expression of the foot and mouth disease virus protease in E. coli, in: The Impact of Gene Transfer Techniques in Eucaryotic Cell Biology (J. S. Schell and P. Starlinger, eds.), pp. 202–209, Springer-Verlag, Berlin.Google Scholar
  53. 53.
    Willingham, M. C., Pastan, I., 1985, An Atlas of Immunofluorescence in Cultured Cells, Academic, New York.Google Scholar
  54. 54.
    Burch, G. E., 1975, Ultrastructural myocardial changes produced by viruses, Rec. Adv. Stud. Card. Struct. Metab. 6:501–523.Google Scholar
  55. 55.
    Goldberg, R. J., and Crowell, R. L., 1971, Susceptibility of differentiating muscle cells of fetal mouse in culture to coxsackievirus A13,J.Virol. 7:759–769.PubMedGoogle Scholar
  56. 56.
    Crowell, R. L., and Syverton, J. T., 1961, The mammalian cell-virus relationship. VI. Sustained infection of HeLa cells by Coxsackie B3 virus and effect on superinfection,J.Exp. Med. 113:419–435.PubMedCrossRefGoogle Scholar
  57. 57.
    Takemoto, K. K., and Habel, K., 1959, Virus-cell relationship in a carrier culture of HeLa cells and Coxsackie A9 virus, Virology 7:28–44.PubMedCrossRefGoogle Scholar
  58. 58.
    Matteucci, D., Paglianti, M., Giangregorio, A. M., Capobianchi, M. R., Dianzani, F., and Bendinelli, M., 1985, Group B coxsackieviruses readily establish persistent infections in human lymphoid cell lines,J.Virol. 56:651–654.PubMedGoogle Scholar
  59. 59.
    Brahic, M., Haase, A. T., and Cash, E., 1984, Simultaneous in situ detection of viral RNA and antigens, Proc. Natl. Acad. Sci. USA 81:5445–5448.PubMedCrossRefGoogle Scholar
  60. 60.
    Blalock, J. E., and Stanton, J. D., 1980, Common pathways of interferon and hormonal action, Nature (Lond.) 283:406–408.CrossRefGoogle Scholar
  61. 61.
    Lampidis, T. J., and Brouty-Boyé, D., 1981, Interferon inhibits cardiac cell function in vitro, Proc. Soc. Exp. Biol. Med. 116:181–185.Google Scholar
  62. 62.
    Aguet, M., Groebke, M., and Dreiding, Ph., 1983, Downregulation of interferon receptors, in: The Biology of the Interferon System (E. De Maeyer and M. Schellekens, eds.), pp. 161–170, Elsevier, Amsterdam.Google Scholar
  63. 63.
    Kahn, C. R., 1979, The role of insulin receptors and receptor antibodies in states of altered insulin action, Proc. Soc. Exp. Biol. Med. 162:13–21.PubMedGoogle Scholar
  64. 64.
    Kandolf, R., Ameis, D., Kirschner, P., Canu, A., and Hofschneider, P. H., 1987, In situ detection of entero viral genomes in myocardial cells by nucleic acid hybridization: An approach to the diagnosis of viral heart disease, Proc. Natl. Acad. Sci. USA 84:6272–6276.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1988

Authors and Affiliations

  • Reinhard Kandolf
    • 1
    • 2
  1. 1.Department of VirologyMax Planck Institute for BiochemistryMartinsriedGermany
  2. 2.Department of Internal Medicine I, Klinikum GrosshadernUniversity of MunichMunich 70Federal Republic of Germany

Personalised recommendations